LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 74.22 | 84.90 | 1563 | 9343 | 0.1673 | 0.5365 | MN20160318_Q02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 74.22 | 84.90 | 7193 | 9343 | 0.7698 | 0.9243 | MN20160318_Q02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 75.93 | 84.90 | 1392 | 8970 | 0.1552 | 0.5159 | MN20160318_Q02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 75.93 | 84.90 | 7457 | 8970 | 0.8313 | 0.9458 | MN20160318_Q02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 75.93 | 84.90 | 1454 | 8970 | 0.1621 | 0.5258 | MN20160318_Q02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 75.93 | 84.90 | 7400 | 8970 | 0.8249 | 0.9436 | MN20160318_Q02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 77.64 | 84.90 | 1509 | 9245 | 0.1632 | 0.5300 | MN20160318_Q02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 77.64 | 84.90 | 7680 | 9245 | 0.8307 | 0.9459 | MN20160318_Q02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 77.64 | 84.90 | 1616 | 9245 | 0.1748 | 0.5456 | MN20160318_Q02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 77.64 | 84.90 | 7579 | 9245 | 0.8197 | 0.9421 | MN20160318_Q02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 79.34 | 84.90 | 1505 | 9051 | 0.1663 | 0.5324 | MN20160318_Q02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 79.34 | 84.90 | 7847 | 9051 | 0.8669 | 0.9581 | MN20160318_Q02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 79.34 | 84.90 | 1512 | 9051 | 0.1670 | 0.5334 | MN20160318_Q02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 79.34 | 84.90 | 7766 | 9051 | 0.8580 | 0.9550 | MN20160318_Q02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 81.05 | 84.90 | 1548 | 8863 | 0.1746 | 0.5418 | MN20160318_Q02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 81.05 | 84.90 | 8122 | 8863 | 0.9163 | 0.9741 | MN20160318_Q02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 81.05 | 84.90 | 1617 | 8863 | 0.1824 | 0.5518 | MN20160318_Q02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 81.05 | 84.90 | 8009 | 8863 | 0.9036 | 0.9700 | MN20160318_Q02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 82.75 | 84.90 | 1424 | 8621 | 0.1652 | 0.5265 | MN20160318_Q02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 82.75 | 84.90 | 8376 | 8621 | 0.9715 | 0.9914 | MN20160318_Q02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 82.75 | 84.90 | 1571 | 8621 | 0.1822 | 0.5492 | MN20160318_Q02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 82.75 | 84.90 | 8234 | 8621 | 0.9551 | 0.9863 | MN20160318_Q02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 84.45 | 84.90 | 1388 | 8254 | 0.1681 | 0.5268 | MN20160318_Q02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 84.45 | 84.90 | 8590 | 8254 | 1.0406 | 1.0121 | MN20160318_Q02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 84.45 | 84.90 | 1602 | 8254 | 0.1941 | 0.5603 | MN20160318_Q02 | D18 |